Lunai Bioworks Inc. (LNAI) investor group discloses 9.41% stake in Schedule 13G

Rhea-AI Filing Summary

Lunai Bioworks Inc. has a significant shareholder group led by Hans Christian Hansen and two Denmark private limited liability companies, Hansen5751H ApS and Hansen5751V ApS. Together, these reporting persons may be deemed to beneficially own 426,650 shares of Lunai Bioworks common stock.

The filing states this position represents approximately 9.41% of the 4,533,890 shares outstanding as of May 22, 2026, based on figures disclosed by the company. All 426,650 shares are reported with shared voting and dispositive power, and none with sole voting or dispositive power, reflecting coordinated ownership among Mr. Hansen and the two ApS entities.

Key Figures

Beneficial ownership: 426,650 shares Ownership percentage: 9.41% Shares outstanding: 4,533,890 shares +4 more

7 metrics

Beneficial ownership 426,650 shares Shares of Lunai Bioworks common stock beneficially owned by the reporting persons

Ownership percentage 9.41% Portion of Lunai Bioworks outstanding common stock represented by 426,650 shares

Shares outstanding 4,533,890 shares Lunai Bioworks common shares outstanding as of May 22, 2026

Direct holdings by Mr. Hansen 178,250 shares Shares of Lunai Bioworks common stock held directly by Hans Christian Hansen

Hansen5751H ApS holdings 90,600 shares Lunai Bioworks shares held by Hansen5751H ApS

Hansen5751V ApS holdings 157,800 shares Lunai Bioworks shares held by Hansen5751V ApS

Shared voting power 426,650 shares Number of shares over which the reporting persons share voting power

Key Terms

beneficial ownership, shared voting power, shared dispositive power, private limited liability entities, +1 more

5 terms

beneficial ownership financial

"As of the date hereof, Mr. Hansen may be deemed to have beneficial ownership of 426,650 Shares"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

shared voting power financial

"Shared power to vote or to direct the vote: 426,650"

Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.

shared dispositive power financial

"Shared power to dispose or to direct the disposition of: 426,650"

private limited liability entities financial

"Each of Hansen5751H and Hansen5751V are Denmark private limited liability entities"

Schedule 13G regulatory

"All percentages of Shares outstanding contained herein are based on 4,533,890 Shares"

A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/17/2026 - 03:23 PM Accepted by SEC EDGAR 07/17/2026 - 03:22 PM Learn about SEC filing dates

FAQ

How many Lunai Bioworks Inc. (LNAI) shares are reported as beneficially owned in this Schedule 13G?

The reporting group led by Hans Christian Hansen reports beneficial ownership of 426,650 shares of Lunai Bioworks common stock. This total aggregates shares held directly by Mr. Hansen and through Hansen5751H ApS and Hansen5751V ApS.

What percentage of Lunai Bioworks Inc. (LNAI) does Hans Christian Hansen’s group own?

The reporting persons state they beneficially own approximately 9.41% of Lunai Bioworks’ outstanding common stock. This percentage is based on 4,533,890 shares outstanding as of May 22, 2026, as disclosed by the company.

What is the total number of Lunai Bioworks Inc. (LNAI) shares outstanding used in this filing?

The ownership percentages are calculated using 4,533,890 shares of Lunai Bioworks common stock outstanding. This share count is stated as of May 22, 2026, referencing the company’s Form 8-K filed on May 20, 2026.

How are the 426,650 Lunai Bioworks Inc. (LNAI) shares held among the reporting persons?

The 426,650 shares are described as 90,600 held by Hansen5751H ApS, 157,800 held by Hansen5751V ApS, and 178,250 shares held directly by Hans Christian Hansen. Each reporting person may be deemed to share voting and dispositive power over all 426,650 shares.

Does Hans Christian Hansen have sole or shared voting power over Lunai Bioworks Inc. (LNAI) shares?

The filing reports 0 shares with sole voting power and 426,650 shares with shared voting power. The same amounts apply to dispositive power, indicating all reported shares are controlled on a shared basis among the reporting persons.

Who are the reporting persons in the Lunai Bioworks Inc. (LNAI) Schedule 13G?

The Schedule 13G is jointly filed by Hans Christian Hansen, Hansen5751H ApS, and Hansen5751V ApS. The two ApS entities are Denmark private limited liability companies owned and controlled by Mr. Hansen, who exercises voting and investment power over their holdings.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Lunai Bioworks Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

23950E302

(CUSIP Number)

05/22/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 23950E302

1

Names of Reporting Persons

Hansen Hans Christian

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DENMARK

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 426,650.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 426,650.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

426,650.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.4 %

12

Type of Reporting Person (See Instructions)

IN, HC

SCHEDULE 13G

CUSIP Number(s): 23950E302

1

Names of Reporting Persons

Hansen5751H ApS

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DENMARK

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 426,650.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 426,650.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

426,650.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.4 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP Number(s): 23950E302

1

Names of Reporting Persons

Hansen5751V ApS

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DENMARK

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 426,650.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 426,650.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

426,650.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.4 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Lunai Bioworks Inc.
(b)	Address of issuer's principal executive offices: 3400 Cottage Way, Suite G2 #32562, Sacramento, CALIFORNIA, 95825.
Item 2.
(a)	Name of person filing: This Schedule 13G is being jointly filed by Hans Christian Hansen, an individual (?Mr. Hansen?), Hansen5751H ApS (?Hansen5751H?) and Hansen5751V ApS (?Hansen5751V? and, together with Hansen5751H and Mr. Hansen, collectively, the ?Reporting Persons?). Each of Hansen5751H and Hansen5751V are Denmark private limited liability entities owned and controlled by Mr. Hansen and in such capacity, exercises the sole voting and investment power over the Shares of the Company held for the account of their respective accounts.
(b)	Address or principal business office or, if none, residence: Pr?stemosevej 10B 3480 Fredensborg Denmark
(c)	Citizenship: Mr. Hansen is a citizen of Denmark. Each of Hansen5751H and Hansen5751V are Denmark private limited liability entities.
(d)	Title of class of securities: Common Stock
(e)	CUSIP Number(s): 23950E302
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: All percentages of Shares outstanding contained herein are based on 4,533,890 Shares of the Company issued and outstanding as of May 22, 2026 as disclosed on the Company?s Form 8-K filed with the SEC on May 20, 2026. (a) Mr. Hansen As of the date hereof, Mr. Hansen may be deemed to have beneficial ownership of 426,650 Shares, representing 90,600 held by Hansen5751H ApS, 157,800 shares held by Hansen5751V ApS, and 178,250 Shares held by Mr. Hansen directly. The Shares beneficially owned by Mr. Hansen as of the date hereof represent approximately 9.41% of the total outstanding Shares. Mr. Hansen may be deemed to share the power to vote or direct the vote and dispose or direct the disposition of all of the 426,650 Shares with Hansen5751H ApS and Hansen5751H ApS. (b) Hansen5751H ApS As of the date hereof, Hansen5751H ApS may be deemed to have beneficial ownership of 426,650 Shares, representing 90,600 held directly, 157,800 shares held by Hansen5751V ApS, and 178,250 Shares held by Mr. Hansen. The Shares beneficially owned by Hansen5751H ApS as of the date hereof represent approximately 9.41% of the total outstanding Shares. Hansen5751H ApS may be deemed to share the power to vote or direct the vote and dispose or direct the disposition of all of the 426,650 Shares with Mr. Hansen and Hansen 5751V ApS. (c) Hansen5751V ApS As of the date hereof, Hansen5751V ApS may be deemed to have beneficial ownership of 426,650 Shares, representing 90,600 held by Hansen 5751H, 157,800 shares held directly, and 178,250 Shares held by Mr. Hansen. The Shares beneficially owned by Hansen5751V ApS as of the date hereof represent approximately 9.41% of the total outstanding Shares. Hansen5751V ApS may be deemed to share the power to vote or direct the vote and dispose or direct the disposition of all of the 426,650 Shares with Mr. Hansen and Hansen 5751H ApS.
(b)	Percent of class: 9.41%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 426,650
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 426,650
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Hansen Hans Christian

Signature:	/s/ Hans Christian Hansen
Name/Title:	Individual
Date:	07/17/2026

Hansen5751H ApS

Signature:	/s/ Hans Christian Hansen
Name/Title:	Authorized Signatory
Date:	07/17/2026

Hansen5751V ApS

Signature:	/s/ Hans Christian Hansen
Name/Title:	Authorized Signatory
Date:	07/17/2026